首页> 美国卫生研究院文献>OncoTargets and therapy >Prognostic significance of platelet-to-lymphocyte ratio in non-small-cell lung cancer: a meta-analysis

【2h】

Prognostic significance of platelet-to-lymphocyte ratio in non-small-cell lung cancer: a meta-analysis

机译：非小细胞肺癌中血小板与淋巴细胞比率的预后意义：一项荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThe platelet-to-lymphocyte ratio (PLR) is a useful predictive factor in several cancers. However, the prognostic value of PLR in patients with non-small-cell lung cancer (NSCLC) is still indistinct. Therefore, it was necessary for us to perform a meta-analysis to assess the prognostic value of PLR in patients with NSCLC.

机译：背景技术血小板与淋巴细胞之比（PLR）是多种癌症中的有用预测因素。然而，PLR在非小细胞肺癌（NSCLC）患者中的预后价值仍然不清楚。因此，我们有必要进行荟萃分析以评估PLR在NSCLC患者中的预后价值。

著录项

期刊名称 OncoTargets and therapy
作者
Guangliang Qiang; Chaoyang Liang; Fei Xiao; Qiduo Yu; Huanshun Wen; Zhiyi Song; Yanchu Tian; Bin Shi; Yongqing Guo; Deruo Liu;
展开▼
作者单位

展开▼
年(卷),期 2016(9),-1
年度 2016
页码 869–876
总页数 8
原文格式 PDF
正文语种
中图分类应用微生物学;肿瘤学;
关键词
non-small cell lung cancer platelet-to-lymphocyte ratio prognosis meta-analysis overall survival disease-free survival;

机译：非小细胞肺癌;血小板与淋巴细胞比率;预后;荟萃分析;总生存期;无病生存期;

相似文献

外文文献
中文文献
专利

1. Prognostic significance of platelet-to-lymphocyte ratio in non-small-cell lung cancer: a meta-analysis [J] . Guangliang Qiang, Chaoyang Liang, Fei Xiao, OncoTargets and therapy . 2016,第6期

机译：非小细胞肺癌中血小板与淋巴细胞比率的预后意义：一项荟萃分析
2. Prognostic significance of combined preoperative platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in patients undergoing surgery with stage IB non-small-cell lung cancer [J] . Yongqiang Chen, Weidong Wang, Xuewen Zhang, Cancer Management and Research . 2018,第1期

机译：合并IB期非小细胞肺癌患者术前血小板与淋巴细胞比例和淋巴细胞与单核细胞比例的联合预后意义
3. Prognostic significance of combined preoperative platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in patients undergoing surgery with stage IB non-small-cell lung cancer [J] . Yongqiang Chen, Weidong Wang, Xuewen Zhang, Cancer Management and Research . 2018,第2016期

机译：合并IB期非小细胞肺癌患者术前血小板与淋巴细胞比例和淋巴细胞与单核细胞比例的联合预后意义
4. Matrix Regenerative Nanoparticles to Improve the Tumor Microenvironment in Non-Small-Cell Lung Cancers [C] . Dhruv R. Seshadri, Anand Ramamurthi Society for Biomaterials annual meeting and exposition . 2018

机译：基质再生纳米颗粒改善非小细胞肺癌的肿瘤微环境
5. Subgroup analysis based on prognostic and predictive gene signatures for adjuvant chemotherapy in early-stage non-small-cell lung cancer patients [D] . Pluta, Dustin. 2015

机译：基于预后和预测基因特征的亚组分析用于早期非小细胞肺癌患者的辅助化疗
6. Prognostic significance of combined preoperative platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in patients undergoing surgery with stage IB non-small-cell lung cancer [O] . Yongqiang Chen, Weidong Wang, Xuewen Zhang, 2018

机译：合并IB期非小细胞肺癌患者术前血小板与淋巴细胞比例和淋巴细胞与单核细胞比例的联合预后意义
7. Prognostic significance of platelet-to-lymphocyte ratio in non-small-cell lung cancer: a meta-analysis [O] . Guangliang Qiang, Chaoyang Liang, Fei Xiao, 2016

机译：非小细胞肺癌血小板到淋巴细胞比例的预后意义：META分析

Prognostic significance of platelet-to-lymphocyte ratio in non-small-cell lung cancer: a meta-analysis

摘要

著录项

相似文献

相关主题

期刊订阅